8-KLeadership ChangesExhibits & Filings

Johnson Controls International plc 8-K Report, Executive Changes (Dec 11, 2017)

Filed December 11, 2017For Securities:JCI

Summary

This 8-K filing from Johnson Controls International plc (JCI) on December 11, 2017, primarily details changes to executive compensation and severance agreements, most notably concerning CEO George Oliver. Mr. Oliver voluntarily terminated his existing Executive Employment Agreement. In exchange, he will now be governed by the company's amended and restated Severance and Change in Control Policy, specifically the provisions applicable to the CEO. This move means Mr. Oliver foregoes the specific severance and change of control benefits outlined in his previous agreement. The filing also outlines significant revisions to the company's Severance and Change in Control Policy for Officers. These amendments aim to align the company's executive compensation and severance practices with market standards and shareholder expectations. Key changes include revised severance multiples (increased for the CEO and other officers), pro-rata vesting of equity awards upon certain terminations, and the inclusion of pro-rata annual bonus payments under specific circumstances related to involuntary termination or good reason resignation following a change in control. The revised policy also strengthens restrictive covenants such as non-competition and non-solicitation.

Key Highlights

  • 1CEO George Oliver voluntarily terminated his prior Executive Employment Agreement.
  • 2Mr. Oliver will now be subject to the terms of the company's amended Severance and Change in Control Policy for Officers.
  • 3The company amended and restated its Severance and Change in Control Policy for Officers, effective December 7, 2017.
  • 4Revised CEO severance benefits include 2x base salary + target bonus and 24 months of health benefits for involuntary termination without cause prior to a change in control.
  • 5Post-change in control, the CEO is entitled to 3x base salary + target bonus and 36 months of health benefits for involuntary termination without cause or good reason resignation.
  • 6Severance benefits for other participating officers were also revised, with multipliers of 1.5x (pre-change in control) and 2x (post-change in control) of base salary + target bonus.
  • 7All equity awards will vest pro rata upon involuntary termination without cause, subject to performance goals.

Frequently Asked Questions